NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE128167 Query DataSets for GSE128167
Status Public on Mar 01, 2020
Title Different Gene Expression Profile in Spontaneously Hypertensive Rats Treated with Songling Xuemaikang Capsule
Organism Rattus norvegicus
Experiment type Expression profiling by array
Summary To study in vivo action of Songling Xuemaikang Capsule (SXC), SHRs were orally administration with high- or low-dose of SXC for 28 days.Valsartan, an angiotensin receptor antagonist, is used as a positive control drug in this study and orally administrated for 28 days. The levels of AngII, Aldosterone in serum of SHRs from different groups were analyzed, and gene expression profiling were performed in the thoracic aortakidney of SHRs, using the Whole Rat Genome Oligonucleotide Microarray. The integrated causal network analysis is performed to understand the mechanism of antihypertensive effect of SXC. The results showed that expression of 706 unique genes (p<0.05) were changed (fold change >2.0) in SHRs at a dose of 472.5 mg/kg day SXC when compared with control rats, whereas the expression of 920 unique genes were changed (fold change>2.0) at a dose of 1417.5 mg/kg/day. Those genes are involved in lipid metabolism, complement system induced immune response, inflammation and vascular and endothelial dysfunction.
 
Overall design SHRs were randomly divided into three groups : model group (n = 8), rats were orally administered with saline (7.5mL.kg-1) for 4 weeks; SXC low-dose group(n = 6), rats were orally administered with SXC (236.25 mg.kg-1) for 4 weeks; SXC high-dose group (n = 6), rats were orally administered with SXC (708.75 mg.kg-1) for 4 weeks; the positive group (n=8), rats were orally administered with valsartan (21.6mg.kg-1) for 4 weeks.
 
Contributor(s) Xu K, Liu L
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Mar 12, 2019
Last update date Mar 03, 2020
Contact name Ke Xu
E-mail(s) [email protected]
Organization name Chengdu Kanghong Pharmaceutical Co. Ltd.
Street address No.36, Shuxi Road
City Cheng Du
State/province SiChuan
ZIP/Postal code 610041
Country China
 
Platforms (1)
GPL14746 Agilent-028282 Whole Rat Genome Microarray 4x44K v3 (Probe Name version)
Samples (26)
GSM3666061 thoracic_aorta_saline_rep1
GSM3666062 thoracic_aorta_saline_rep2
GSM3666063 thoracic_aorta_saline_rep3
Relations
BioProject PRJNA526671

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE128167_RAW.tar 55.5 Mb (http)(custom) TAR (of TXT)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap